MedTrace Logo

Muco-ciliary Cleansing of Lungs in COPD With and Without a Salt Particle Inhaler

NCT03927365 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2021-01-15

No results posted yet for this study

Summary

Cross-over trial of the effect of a salt particle inhaler on pulmonary muco-ciliary cleansing in COPD patients as measured by lung scintigraphy.

Conditions

  • COPD
  • Copd Bronchitis

Interventions

DEVICE

Inhalation from a salt particle inhaler with or without content

Inhalation from inhaler with (active) or without (placebo) content

Sponsors & Collaborators

  • Liita Care ApS

    lead INDUSTRY

Principal Investigators

  • Jann Mortensen, MD Professor · Rigshospitalet, Clin Nuclear & Physiolog dept.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2021-04-30
Completion
2021-05-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03927365 on ClinicalTrials.gov